Myalgic encephalomyelitis/chronic fatigue syndrome patients' reports of symptom changes following cognitive behavioural therapy, graded exercise therapy and pacing treatments: Analysis of a primary survey compared with secondary surveys. — CFSMEATLAS
Myalgic encephalomyelitis/chronic fatigue syndrome patients' reports of symptom changes following cognitive behavioural therapy, graded exercise therapy and pacing treatments: Analysis of a primary survey compared with secondary surveys.
Geraghty, Keith, Hann, Mark, Kurtev, Stoyan · Journal of health psychology · 2019 · DOI
Quick Summary
This study asked ME/CFS patients about their experiences with three different treatment approaches: cognitive behavioural therapy (CBT), graded exercise therapy (GET), and pacing. The researchers found that pacing—where patients carefully manage their activity levels without pushing beyond their limits—was reported as most helpful and caused the fewest problems. In contrast, GET led to significant symptom worsening in over half of patients, while CBT helped only a small percentage of people.
Why It Matters
This research directly addresses a significant disconnect between current clinical guidelines promoting GET and CBT versus patient-reported experiences of harm, particularly with GET. The large sample size and consistency across multiple surveys strengthens the evidence that treatment responses are heterogeneous and that pacing may be undervalued despite patient preference and reported safety profiles. These findings support the need for individualised treatment approaches and greater patient involvement in treatment selection.
Observed Findings
Pacing was reported as beneficial by 44-82% of patients across surveys, with negative response rates of 5-20%
GET produced negative responses in 54-74% of patients across multiple surveys
CBT was reported as beneficial by only 8-35% of patients
Consistency in findings across primary and secondary surveys despite different patient populations
Substantial variability in individual responses within each treatment category
Inferred Conclusions
Pacing may be a safer and more effective treatment approach than currently promoted therapies for many ME/CFS patients
GET carries significant risk of symptom deterioration and should be reconsidered as a standard treatment recommendation
Current evidence-based treatment guidelines may not reflect actual patient experiences and outcomes
ME/CFS treatment responses are highly individualised and one-size-fits-all approaches may be inappropriate
Remaining Questions
What patient characteristics predict positive versus negative responses to each treatment modality?
Do objective measures (biomarkers, activity data) correlate with patient-reported symptom changes?
What This Study Does Not Prove
This study cannot establish causation or prove that GET causes harm in all patients, as it relies on patient recall and self-reported outcomes without objective biomarkers, control groups, or blinded assessment. The cross-sectional design prevents determination of whether baseline differences between treatment groups explain outcome variations. It does not identify which patient subgroups might benefit from each approach or explain the mechanisms underlying differential responses.